Pharmacological prevention of atrial tachycardia induced atrial remodeling as a potential therapeutic strategy.
- 1 March 2003
- journal article
- review article
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 26 (3) , 752-764
- https://doi.org/10.1046/j.1460-9592.2003.00128.x
Abstract
No abstract availableKeywords
This publication has 87 references indexed in Scilit:
- Dilated Left Atrium and Pulmonary Veins in Patients with Calcified Coronary Artery: A Potential Contributor to the Genesis of Atrial FibrillationJournal of Cardiovascular Electrophysiology, 2009
- KB-R7943 Prevents Acute, Atrial Fibrillation–Induced Shortening of Atrial Refractoriness in Anesthetized DogsCirculation, 2002
- New ideas about atrial fibrillation 50 years onNature, 2002
- High affinity interaction of mibefradil with voltage‐gated calcium and sodium channelsBritish Journal of Pharmacology, 2000
- Alterations in Gene Expression of Proteins Involved in the Calcium Handling in Patients with Atrial FibrillationJournal of Cardiovascular Electrophysiology, 1999
- Clinical Pharmacokinetics of MibefradilClinical Pharmacokinetics, 1998
- Effects of a New Na+/H+ Antiporter Inhibitor on Postischemic Reperfusion in Pig HeartJournal of Cardiovascular Pharmacology, 1994
- Changes in left atrial size in patients with lone atrial fibrillationClinical Cardiology, 1991
- Intracellular pH and role of Na+/H+ exchange during ischaemia and reperfusion of normal and diabetic rat heartsCardiovascular Research, 1990
- The Natural History of Lone Atrial FibrillationNew England Journal of Medicine, 1987